Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03720210 · ClinicalTrials.gov registry record · NA
Radiofrequency Ablation for Amiodarone-induced Thyrotoxicosis
A NA study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT03720210: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT03720210 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03720210, a NA study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
Investigators intend to study the changes in thyroid hormone storage and production in amiodarone-induced thyrotoxicosis patients after RFA therapy.
Interventions
- DEVICE RFA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2018-11-19 |
| Est. Completion | 2020-12-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03720210
The ClinicalTrials.gov registry entry for NCT03720210 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RFA is the first listed.
NCT03720210 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03720210 about?
NCT03720210 is a clinical study titled "Radiofrequency Ablation for Amiodarone-induced Thyrotoxicosis". Investigators intend to study the changes in thyroid hormone storage and production in amiodarone-induced thyrotoxicosis patients after RFA therapy.
What is the current status of trial NCT03720210?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2018-11-19. Estimated completion is 2020-12-07.
What interventions are being tested in trial NCT03720210?
The interventions under investigation include: RFA (DEVICE).
Who is sponsoring clinical trial NCT03720210?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.